Search
Aerovate Therapeutics Inc
AVTEAdd to Watchlist
2.680USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
77.68MMarket Cap
LossP/E TTM
Aerovate Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-2.44
15.06%
Analyst Rating
STRONG BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the net investment of Aerovate Therapeutics Inc?
According to Aerovate Therapeutics Inc's FY2024 earnings report, its net investment of Aerovate Therapeutics Inc was 56.03M, with a year-on-year change of 371.78.
What is the net financing of Aerovate Therapeutics Inc?
According to Aerovate Therapeutics Inc's FY2024 earnings report, its net financing of Aerovate Therapeutics Inc was 25.43M, with a year-on-year change of -44.72.
What is the Earnings Per Share (EPS) of Aerovate Therapeutics Inc?
According to Aerovate Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -2.44, with a year-on-year change of 15.06.
What is the Return on Equity (ROE) of Aerovate Therapeutics Inc?
According to Aerovate Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -74.91, with a year-on-year change of -17.15.
What is the Return on Assets (ROA) of Aerovate Therapeutics Inc?
According to Aerovate Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -67.03, with a year-on-year change of -16.59.
What is the operating profit of Aerovate Therapeutics Inc?
According to Aerovate Therapeutics Inc's FY2024 earnings report, its operating profit was -74.60M, with a year-on-year change of 8.37.